NCT03502785: An ongoing trial by Inovio Pharmaceuticals
This trial is ongoing. It must report results 4 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03502785 |
|---|---|
| Title | An Open-Label, Multi-Center Trial of INO-5401 + INO-9012 in Combination With Atezolizumab in Subjects With Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 24, 2018 |
| Completion date | May 9, 2025 |
| Required reporting date | May 9, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |